Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Williams

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Gene Therapy|August 22, 2014
Improving DNA vaccine performance through vector designJames A Williams
Vaccines|September 8, 2015
Vector Design for Improved DNA Vaccine Efficacy, Safety and ProductionJames A Williams
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Plasmid fermentation process for DNA immunization applicationsAaron E Carnes, James A Williams
Molecular Therapy. Nucleic Acids|June 22, 2023
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectorsJames A Williams, Patrick A Paez
Langmuir : the ACS Journal of Surfaces and Colloids|February 16, 2007
Scanning tunneling microscopy-based replacement lithography on self-assembled monolayers: comparison of gold, palladium, and platinum substratesJames A Williams, Christopher B Gorman
Journal of Pediatric Hematology/Oncology|March 7, 2003
Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescentsJames A Williams, Laurence A Boxer
Recent Patents on Biotechnology|December 17, 2008
Plasmid DNA manufacturing technologyAaron E Carnes, James A Williams
Molecular Biotechnology|May 21, 2009
Strain engineering by genome mass transfer: efficient chromosomal trait transfer method utilizing donor genomic DNA and recipient recombineering hostsJames A Williams, Jeremy Luke, Clague Hodgson
The Israel Medical Association Journal : IMAJ|December 20, 2002
Rituximab for refractory childhood autoimmune hemolytic anemiaDavid G Motto, James A Williams, Laurence A Boxer
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Development of antibiotic-free selection system for safer DNA vaccinationJeremy M Luke, Aaron E Carnes, James A Williams
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Gene Therapy|August 22, 2014
Improving DNA vaccine performance through vector designJames A Williams
Vaccines|September 8, 2015
Vector Design for Improved DNA Vaccine Efficacy, Safety and ProductionJames A Williams
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Plasmid fermentation process for DNA immunization applicationsAaron E Carnes, James A Williams
Molecular Therapy. Nucleic Acids|June 22, 2023
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectorsJames A Williams, Patrick A Paez
Langmuir : the ACS Journal of Surfaces and Colloids|February 16, 2007
Scanning tunneling microscopy-based replacement lithography on self-assembled monolayers: comparison of gold, palladium, and platinum substratesJames A Williams, Christopher B Gorman
Journal of Pediatric Hematology/Oncology|March 7, 2003
Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescentsJames A Williams, Laurence A Boxer
Recent Patents on Biotechnology|December 17, 2008
Plasmid DNA manufacturing technologyAaron E Carnes, James A Williams
Molecular Biotechnology|May 21, 2009
Strain engineering by genome mass transfer: efficient chromosomal trait transfer method utilizing donor genomic DNA and recipient recombineering hostsJames A Williams, Jeremy Luke, Clague Hodgson
The Israel Medical Association Journal : IMAJ|December 20, 2002
Rituximab for refractory childhood autoimmune hemolytic anemiaDavid G Motto, James A Williams, Laurence A Boxer
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Development of antibiotic-free selection system for safer DNA vaccinationJeremy M Luke, Aaron E Carnes, James A Williams
Pageof 8